BPA for matulane
Ended Awarded Last action
- Contract number
- 36E79722A0005
- Awardee
-
Leadiant Biosciences, Inc. UEI XEEKF6DJLC34
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- VA797P12Q0002 Solicitation number
- Last date to order 100% complete
- IDV ceiling
- $465,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
Leadiant Biosciences, Inc. U.S. Division was awarded a single-award Blanket Purchase Agreement (BPA) by the National Acquisition Center on October 21, 2021, for the supply of Matulane, a chemotherapy pharmaceutical product. This BPA carries a ceiling value of $465,000 and operates under the parent Federal Supply Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB), with performance continuing through October 20, 2026. No set-aside designation was applied to this award, indicating the contract was competed in full and open competition. The BPA streamlines the procurement process for Veterans Affairs medical facilities requiring this specialized cancer treatment, eliminating the need for individual solicitations and purchase orders for routine Matulane requirements.
The contract's primary objective is to ensure consistent availability of Matulane across the VA healthcare system while incorporating pricing updates through 2026 to reflect statutory requirements. Leadiant Biosciences' pharmaceutical manufacturing capabilities and track record supplying Matulane to Veterans Integrated Service Networks demonstrate the contractor's operational capacity to fulfill this specialized requirement. This BPA structure, functioning as a subordinate vehicle under the broader FSS contract, enables VA medical centers to issue delivery orders efficiently while maintaining centralized pricing and terms established at the BPA level. The arrangement reflects the federal government's procurement strategy for managing recurring pharmaceutical supply needs within the VA's cancer treatment and chemotherapy programs.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Show all 13
Quick answers
Who was awarded contract 36E79722A0005?
36E79722A0005 was awarded to Leadiant Biosciences, Inc. by National Acquisition Center (Headquarters) on October 21, 2021.
How much is contract 36E79722A0005 worth?
36E79722A0005's own ceiling is $465,000.
Who can order from contract 36E79722A0005?
36E79722A0005 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 36E79722A0005 under another contract?
Yes. 36E79722A0005 is a blanket purchase agreement under 36F79721D0236, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36E79722A0005 competed?
The extent of competition for 36E79722A0005 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV